https://www.selleckchem.com/pr....oducts/acetylcystein
irect treatment comparison trials between CDK4/6 inhibitors are completed in the future. DISCLOSURES No outside funding supported this study. The authors have nothing to disclose.BACKGROUND Hypoglycemia is a major limiting factor in achieving glycemic control in persons with diabetes. In some instances, recovery from a severe hypoglycemia event may require health care resource utilization (HCRU), including the use of emergency medical services (EMS), visits to the emergency department (ED), and inpatient hospitalization. OBJECTIV
Me gusta
Comentario
Compartir
